...
首页> 外文期刊>JMIR mHealth and uHealth >Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points
【24h】

Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points

机译:从Health Professional和Consumer Vantage点评估药物依从性应用程序市场

获取原文
           

摘要

Background Nonadherence produces considerable health consequences and economic burden to patients and payers. One approach to improve medication nonadherence that has gained interest in recent years is the use of smartphone adherence apps. The development of smartphone adherence apps has increased rapidly since 2012; however, literature evaluating the clinical app and effectiveness of smartphone adherence apps to improve medication adherence is generally lacking. Objective The aims of this study were to (1) provide an updated evaluation and comparison of medication adherence apps in the marketplace by assessing the features, functionality, and health literacy (HL) of the highest-ranking adherence apps and (2) indirectly measure the validity of our rating methodology by determining the relationship between our app evaluations and Web-based consumer ratings. Methods Two independent reviewers assessed the features and functionality using a 4-domain rating tool of all adherence apps identified based on developer claims. The same reviewers downloaded and tested the 100 highest-ranking apps including an additional domain for assessment of HL. Pearson product correlations were estimated between the consumer ratings and our domain and total scores. Results A total of 824 adherence apps were identified; of these, 645 unique apps were evaluated after applying exclusion criteria. The median initial score based on descriptions was 14 (max of 68; range 0-60). As a result, 100 of the highest-scoring unique apps underwent user testing. The median overall user-tested score was 31.5 (max of 73; range 0-60). The majority of the user tested the adherence apps that underwent user testing reported a consumer rating score in their respective online marketplace. The mean consumer rating was 3.93 (SD 0.84). The total user-tested score was positively correlated with consumer ratings ( r =.1969, P =.04). Conclusions More adherence apps are available in the Web-based marketplace, and the quality of these apps varies considerably. Consumer ratings are positively but weakly correlated with user-testing scores suggesting that our rating tool has some validity but that consumers and clinicians may assess adherence app quality differently.
机译:背景技术不遵守将给患者和付款人带来相当大的健康后果和经济负担。近年来,引起人们关注的一种改善药物不依从性的方法是使用智能手机依从性应用程序。自2012年以来,智能手机依从性应用程序的发展迅速增长;但是,通常缺乏评估临床应用和智能手机依从性应用程序对改善药物依从性有效性的文献。目的这项研究的目的是(1)通过评估排名最高的依从性应用程序的功能,功能和健康素养(HL),对市场上的药物依从性应用程序进行更新的评估和比较,以及(2)间接衡量确定我们的应用评估与基于网络的消费者评分之间的关​​系,从而确定评分方法的有效性。方法两名独立的审阅者使用基于开发人员声明确定的所有依从性应用程序的4域评级工具对功能进行了评估。相同的审阅者下载并测试了排名最高的100个应用程序,其中包括用于评估HL的其他域。皮尔森产品的相关性是在消费者评分与我们的领域和总分之间进行估算的。结果共发现824个依从性应用程序;其中,应用排除标准后,评估了645个独特的应用程序。基于描述的中位初始评分为14(最大值为68;范围为0-60)。结果,100个得分最高的独特应用程序经历了用户测试。用户测试的总体总体评分中位数为31.5(最大值为73;范围为0-60)。大多数用户测试了依从性应用程序,这些应用程序经过用户测试后报告了各自在线市场上的消费者评分得分。消费者的平均评分为3.93(SD 0.84)。用户测试的总评分与消费者评分呈正相关(r = .1969,P = .04)。结论基于Web的市场中提供了更多的依从性应用程序,这些应用程序的质量差异很大。消费者评分与用户测试评分呈正相关,但相关性较弱,这表明我们的评分工具具有一定的有效性,但消费者和临床医生对依从性应用质量的评估可能有所不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号